Tag: Schizophrenia

Researchers detect disparity between white and African American patients diagnosed with schizophrenia when symptoms of a mood disorder are present.

The authors outline reasons for renaming schizophrenia and the way a change can reform practice.

A new study examines the effects of CBD as an adjunct therapy to antipsychotic medication for patients diagnosed with schizophrenia.

Review compares the effectiveness of pharmacological and non-pharmacological interventions for improving physical health outcomes in people diagnosed with schizophrenia.

A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioning—and reached full recovery more quickly.

Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.

A new analysis of antipsychotic treatment of schizophrenia (published in Schizophrenia Bulletin) has found that two-thirds of patients treated this way do not experience symptom remission.

Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.

From Reuters, "'At La Fageda, these people don’t have a label – they are totally integrated – and they start improving, reconstructing themselves without...

Researchers investigate the first-person experiences of people who disagreed with their psychiatric diagnosis of psychosis.

Study finds that reduced cortical thickness and brain surface area associated with 'schizophrenia' may result from antipsychotic drug use.

Members of the U.S. Food and Drug Administration’s Psychiatry Products division go on the defensive in a new article, responding to concerns about the agency’s approval of digital aripiprazole.

Coordinated care with employment support and family therapy leads to superior outcomes for those diagnosed with psychotic disorders.

From the New York Times: Americans with depression, bipolar disorder or other serious mental illnesses die 15 to 30 years younger than those without mental...

In this piece for MetroUK, Lucy Nichol explains how to best support people in "psychosis," emphasizing the need to believe individuals who hear voices and recognize...

It really is time to drop the label of schizophrenia, and ISPS Australia invites us to consider just that, in favour of understanding human experience and removing the impediments to a person making sense of their experience — impediments that exist due to the primarily biomedical perspectives that continue to dominate the mental health systems.

In this piece for the Centre for Medical Humanities, James Whitehead reflects on the 25th anniversary celebration of the publication of Louis Sass's Madness and Modernism. "A...

From Harper's Magazine: People who hear positive, encouraging voices often seen as spiritual guides or messages and people diagnosed with schizophrenia are usually thought of as...

If a person recognizes the “alien” parts of themselves as being parts of themselves, they are likely to be seen as having PTSD or a dissociative disorder. If they see the “alien” parts of themselves as being literally aliens, or demons, they will likely be diagnosed as psychotic. But these experiences are really on a spectrum.

There are a number of well-recognised problems with this sort of study and we should be very cautious about accepting its conclusions at face value. The main problem is that it is an ‘observational’ study, not a randomised controlled trial, and these analyses can be seriously misleading. 

Research finds that hearing negative voices explains how childhood adversity is related to distress.

A new study explores how “psychosis” and “schizophrenia” are viewed within the Māori community in New Zealand.

Confronting existential anxiety through “Basal Exposure Therapy” shows promising results in people withdrawing from psychotropic drugs.

With increasing evidence that psychiatric drugs do more harm than good over the long term, the field of psychiatry often seems focused on sifting through the mounds of research data it has collected, eager to at last sit up and cry, here’s a shiny speck of gold! Our drugs do work! One recently published study on withdrawal of antipsychotics tells of long-term benefits. A second tells of long-term harm. Which one is convincing?

A review of mental health anti-stigma campaigns finds psychosocial models are effective in reducing stigma, while biogenetic models often worsen attitudes.